Kochi-based company to start phase 2b trials of COVID drug next week

PNB Vesper Life’s chief executive PN Balaram is upbeat the company’s experimental drug PNB-001 will be effective in treating symptoms of Covid-19. The Kochi-based pharma company is set to begin clinical trials on patients suffering from the disease next week.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cbBKG4
via IFTTT